Scarica l'app Stockscreener
8.77
5.29%
-0.49
Dopo l'orario di chiusura:
8.72
-0.05
-0.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Precedente Chiudi:
$9.26
Aprire:
$9.26
Volume 24 ore:
2.64M
Relative Volume:
0.75
Capitalizzazione di mercato:
$625.38M
Reddito:
-
Utile/perdita netta:
$-192.96M
Rapporto P/E:
-2.6576
EPS:
-3.3
Flusso di cassa netto:
$-167.04M
1 W Prestazione:
+2.81%
1M Prestazione:
+120.35%
6M Prestazione:
+624.79%
1 anno Prestazione:
+291.52%
Intervallo 1D:
$8.155
$9.39
Intervallo di 1 settimana:
$7.80
$9.46
Portata 52W:
$0.783
$9.50
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Nome
Ventyx Biosciences Inc
Settore
Industria
Telefono
(858) 945-2393
Indirizzo
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Confronta VTYX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
8.77 | 660.32M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-05 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Downgrade | Stifel | Buy → Hold |
| 2023-11-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Wells Fargo | Overweight |
| 2022-12-19 | Iniziato | Goldman | Buy |
| 2022-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-07 | Iniziato | Stifel | Buy |
| 2022-09-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-09 | Iniziato | Credit Suisse | Outperform |
| 2022-03-31 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-15 | Iniziato | Jefferies | Buy |
| 2021-11-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Can a trend reversal in Ventyx Biosciences Inc. lead to recoveryJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Is Ventyx Biosciences Inc. still worth holding after the dipRecession Risk & Fast Moving Stock Watchlists - newser.com
Applying Elliott Wave Theory to Ventyx Biosciences Inc.Market Risk Summary & Entry Point Strategy Guides - newser.com
Real time pattern detection on Ventyx Biosciences Inc. stockSell Signal & Fast Exit and Entry Strategy Plans - newser.com
How Ventyx Biosciences Inc. stock performs during Fed tightening cycles2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Will Ventyx Biosciences Inc. see short term momentumWeekly Trend Recap & AI Powered Trade Plan Recommendations - newser.com
Ventyx Biosciences Reports Q3 2025 Financial Results - TipRanks
Ventyx Biosciences Narrows Loss And Wins Wall Street Support - Finimize
Ventyx Biosciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress - The Manila Times
Press Release: Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress - 富途牛牛
Ventyx Biosciences (NASDAQ:VTYX) Trading Up 12.2%What's Next? - MarketBeat
Market reaction to Ventyx Biosciences Inc.’s recent newsJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
What Wall Street predicts for Ventyx Biosciences Inc. stock priceWeekly Trade Recap & AI Optimized Trading Strategy Guides - fcp.pa.gov.br
Will Ventyx Biosciences Inc. stock benefit from infrastructure spendingTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Can Ventyx Biosciences Inc. stock double in next 5 yearsWall Street Watch & Community Verified Swing Trade Signals - newser.com
How risky is Ventyx Biosciences Inc. stock now2025 Earnings Impact & Safe Swing Trade Setup Alerts - fcp.pa.gov.br
Why Ventyx Biosciences Inc. is moving todayMarket Sentiment Report & AI Forecast Swing Trade Picks - newser.com
What sentiment indicators say about Ventyx Biosciences Inc. stockJuly 2025 Highlights & Capital Efficient Trading Techniques - fcp.pa.gov.br
What high frequency data says about Ventyx Biosciences Inc.Portfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
Does Ventyx Biosciences Inc. fit your quant trading modelRisk Management & Weekly Setup with ROI Potential - newser.com
Chart based exit strategy for Ventyx Biosciences Inc.Market Risk Report & Reliable Volume Spike Alerts - newser.com
Technical signs of recovery in Ventyx Biosciences Inc.Chart Signals & Momentum Based Trading Ideas - newser.com
Will Ventyx Biosciences Inc. stock split again soon2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Will Ventyx Biosciences Inc. stock see PE expansion2025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Has Ventyx Biosciences Inc. formed a bullish divergencePrice Action & Precise Trade Entry Recommendations - newser.com
Ventyx Biosciences stock rating upgraded to Buy by H.C. Wainwright - Investing.com Philippines
Will Ventyx Biosciences Inc. stock reach Wall Street targetsJuly 2025 Sector Moves & Safe Capital Growth Tips - fcp.pa.gov.br
Ventyx Biosciences Shares Rise After HC Wainwright Upgrade - MarketScreener
HC Wainwright Upgrades Ventyx Biosciences to Buy From Neutral, $18 Price Target - MarketScreener
HC Wainwright & Co. Upgrades Ventyx Biosciences (VTYX) - Nasdaq
Is Ventyx Biosciences Inc. stock attractive for growth ETFsJuly 2025 Sector Moves & Fast Gain Stock Tips - newser.com
Will Ventyx Biosciences Inc. stock recover faster than peersWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):